The International Registry for Alzheimer’s Disease and Other Dementias Foundation (InRAD) would like to thank and acknowledge the following organisations for their financial contributions:
‍

Eli Lilly and Company Ltd

For their collaborative research agreement to support the data entry portal and registry platform build, medical writing and project management services for Alzheimers Europe 2024, CTAD 2024 and ADPD 2025.
‍

‍

‍

Schwabe Group

For their sponsorship of the InRAD Industry Forum.




‍

Novo Nordisk

For their grant to support medical writing, design and project management services at AAIC 2024.

‍
‍

‍

Bristol Myers Squibb

For their contribution toward supporting the registry platform build.
‍
‍

‍
‍

Other Partnerships:
‍
‍

Alzheimer's Network

InRAD is pleased to announce a collaboration with Alzheimers Network (Alz Net). ALZ-NET is a voluntary health care provider-enrolled patient network and we aim to collaborate to advance goals to improve patient care. Learn more about Alz Net HERE


‍

‍

Icometrix NV

InRAD is pleased to announce a collaboration with Icometrix, a leader in AI-powered neuroimaging solutions, to advance MRI standardisation, ARIA monitoring, and real-world data integration in Alzheimer’s disease care. Learn more about Icometrix HERE




‍

Neurophet

InRAD is pleased to announce a collaboration to enhance clinical workflows in imaging, improve Alzheimer’s diagnosis and care, and collect real-world imaging data. Find out more about Neurophet HERE

The InRAD Foundation does not endorse any companies or products. The InRAD Foundation is operated independently from these companies.